Understanding the Role of Inflammation in Down Syndrome

Inflammation plays a fundamental role in maintaining health and defending the body against infections and injury. However, when inflammation becomes chronic or dysregulated—as is often seen in individuals with Down syndrome—it can contribute to a range of health concerns, from immune dysfunction to cognitive decline.

The Science Behind Personalized Nutrition for Down Syndrome Reading Understanding the Role of Inflammation in Down Syndrome 10 minutes

By Blake ButlerOct 15, 2025

1. Understanding Inflammation and Oxidative Stress in Down Syndrome

Down syndrome is characterized by an extra copy of chromosome 21, which contains several genes involved in immune regulation and oxidative balance. This genetic variation contributes to chronic immune activation, increased production of reactive oxygen species (ROS), and reduced antioxidant defenses.

Studies have found elevated levels of inflammatory markers such as myeloperoxidase, interleukin-1 beta (IL-1β), and interleukin-6 (IL-6) in individuals with Down syndrome. At the same time, antioxidant capacity—measured through markers like glutathione and vitamin E—is often impaired. This imbalance between pro-inflammatory and antioxidant forces can lead to oxidative damage at the cellular level, impacting the brain, heart, thyroid, and other organs.

In short, the body’s defense system is always “on,” creating a background level of inflammation that contributes to the aging process and increases susceptibility to chronic disease.

2. The Systemic Impact of Chronic Inflammation

Chronic, low-grade inflammation can influence nearly every aspect of health in Down syndrome:

Cognitive function: Inflammatory cytokines like IL-6 and IL-1β have been linked to accelerated neurodegeneration and may contribute to early-onset Alzheimer’s disease, which occurs more frequently in individuals with Down syndrome.
Metabolic health: Inflammation interferes with insulin signaling and lipid metabolism, increasing the risk for obesity and metabolic syndrome.
Immune regulation: Constant immune activation can impair the body’s ability to respond appropriately to infections or vaccines.
Gut health: Inflammation in the gastrointestinal tract can affect digestion, nutrient absorption, and even behavior through the gut-brain axis.

These interconnected pathways underscore why targeting inflammation is such a critical step in improving quality of life for individuals with Down syndrome.

3. The Power of Nutrition in Reducing Inflammation

Diet is one of the most powerful levers for regulating inflammation. Studies in children and adolescents with Down syndrome have shown that dietary interventions modeled after the Mediterranean diet—rich in fruits, vegetables, olive oil, nuts, whole grains, and fish—can reduce inflammatory cytokines and improve metabolic markers.

This anti-inflammatory dietary pattern emphasizes:

Healthy fats: Omega-3 fatty acids from fish, algae, flax, or chia help modulate inflammation and support brain health.
Antioxidant-rich foods: Berries, leafy greens, and colorful vegetables supply polyphenols and vitamins C and E that neutralize oxidative stress.
Whole, minimally processed foods: Reducing refined sugars and trans fats helps stabilize blood sugar and minimize inflammatory responses.

Supplementation can also play a role. Nutrients such as vitamin E, vitamin C, alpha-lipoic acid, and polyphenols have demonstrated improvements in oxidative stress markers in clinical studies, though results for cognitive or behavioral outcomes remain mixed. Importantly, these interventions were generally safe, with only isolated reports of mild gastrointestinal symptoms or transient changes in folate levels.

4. The Role of Physical Activity and Weight Management

Lifestyle interventions go hand in hand with nutrition in controlling inflammation. In one study involving 100 obese children, weight loss led to reductions in IL-1, IL-6, and leptin, alongside improvements in adaptive behavior—a meaningful reminder that inflammation is not just a biochemical issue but one that affects day-to-day functioning and development.

Regular movement, even in moderate amounts, improves circulation, enhances mitochondrial function, and reduces systemic inflammation. For individuals with Down syndrome, activities that combine movement with social engagement—such as swimming, walking, or group dance—can provide both physical and emotional benefits.

5. Supporting Antioxidant Defense

Because oxidative stress plays a central role in Down syndrome–related inflammation, strengthening the body’s antioxidant network is essential. This involves:

Boosting glutathione: The body’s master antioxidant can be supported through foods rich in sulfur compounds (like garlic and onions) or precursors such as N-acetylcysteine.
Including magnesium and selenium: These trace minerals help regulate antioxidant enzymes and immune function.
Using polyphenol-rich botanicals: Compounds from green tea, turmeric (curcumin), and cocoa can modulate inflammatory signaling pathways and protect neural tissue.

While supplementation can be helpful, it’s most effective when paired with a nutrient-dense diet and balanced lifestyle.

6. Building a Sustainable, Anti-Inflammatory Lifestyle

Reducing inflammation isn’t about restrictive diets or short-term fixes—it’s about creating a sustainable routine that supports resilience and vitality. For individuals with Down syndrome, this means combining personalized nutrition with consistent movement, good sleep hygiene, stress management, and regular monitoring by a healthcare provider familiar with their unique needs.

Caregivers and families play a central role in shaping these habits, and small, consistent changes—such as incorporating colorful vegetables into meals or setting a daily walk routine—can make a significant impact over time.

Conclusion: Calming the Fire Within

Inflammation may be a common thread in Down syndrome, but it is not an unchangeable one. Through the integration of anti-inflammatory nutrition, targeted antioxidant support, and sustainable lifestyle choices, individuals with Down syndrome can experience improvements in immune function, energy, and overall quality of life.

As research continues to deepen our understanding of the inflammatory processes in Down syndrome, the path forward becomes increasingly clear: by calming the body’s internal inflammation, we can help nurture a stronger foundation for lifelong health and well-being.

Sources:

Ciaccio, M., M. Piccione, M. Giuffré, V. Macaione, L. Vocca, et al. “Aminoacid Profile and Oxidative Status in Children Affected by Down Syndrome Before and After Supplementary Nutritional Treatment.” Italian Journal of Biochemistry, vol. 52, no. 2, 2003, pp. 75–81.
Ferreira, Gabriela Pacheco, and Priscila Berti Zanella. “Síndrome de Down e Nutrição: Uma Revisão Integrativa da Literatura.” Revista Interdisciplinar de Estudos em Saúde, 2025.
Gualandri, W., L. Gualandri, G. Demartini, R. Esposti, P. Marthyn, et al. “Redox Balance in Patients with Down’s Syndrome Before and After Dietary Supplementation with Alpha-Lipoic Acid and L-Cysteine.” International Journal of Clinical Pharmacology Research, vol. 23, no. 2–3, 2003, pp. 79–86.
Gutiérrez-Hervás, A., E. Nova, R. Izquierdo-Gómez, Ó. L. Veiga, Carmen Padilla, et al. “Association Between Lifestyle Patterns and Abdominal Obesity with Biochemical and Inflammatory Biomarkers in Adolescents with Down Syndrome: The UP&DOWN Study.” Nutrients, vol. 16, no. 3, 2024, p. 570.
Huggard, D., L. Kelly, A. Worrall, Eleanor Gallagher, Lida Fallah, et al. “Melatonin as an Immunomodulator in Children with Down Syndrome.” Pediatric Research, vol. 89, no. 4, 2021, pp. 985–992.
Kilany, A., Mohamed E. Elhadidy, Mona M. F. Ganem, N. Nashaat, G. Orabi, et al. “Diet and Physical Activity Modification: Impact on Adaptive Behavior and Biochemical Measures of Children with Down Syndrome.” International Journal of Developmental Disabilities, 2024.
Lakshmi, K., R. Surekha, B. Srikanth, and A. Jyothy. “Serum Cholinesterases in Down Syndrome Children Before and After Nutritional Supplementation.” Singapore Medical Journal, vol. 49, no. 12, 2008, pp. 1002–1005.
Lott, I., E. Doran, Vinh Q. Nguyen, A. Tournay, E. Head, et al. “Down Syndrome and Dementia: A Randomized, Controlled Trial of Antioxidant Supplementation.” American Journal of Medical Genetics, Part A, vol. 155A, no. 8, 2011, pp. 1939–1948.
Manna, C., L. Tagliafierro, Iris Scala, Barbara Granese, G. Andria, et al. “The Role of Iron Toxicity in Oxidative Stress-Induced Cellular Degeneration in Down Syndrome: Protective Effects of Phenolic Antioxidants.” Free Radical Research, vol. 46, no. 2, 2012, pp. 154–163.
Muchová, J., I. Žitňanová, and Z. Ďuračková. “Oxidative Stress and Down Syndrome: Do Antioxidants Play a Role in Therapy?” Physiological Research, vol. 63, no. 5, 2014, pp. 535–542.
Nachvak, S. M., T. Neyestani, S. Mahboob, Siamak Sabour, S. A. Keshawarz, et al. “α-Tocopherol Supplementation Reduces Biomarkers of Oxidative Stress in Children with Down Syndrome: A Randomized Controlled Trial.” European Journal of Clinical Nutrition, vol. 68, no. 1, 2014, pp. 111–114.
Parisotto, E. B., A. G. Giaretta, A. Zamoner, E. Moreira, T. Fröde, et al. “Persistence of the Benefit of an Antioxidant Therapy in Children and Teenagers with Down Syndrome.” Research in Developmental Disabilities, vol. 36, 2015, pp. 564–571.
Parisotto, E. B., T. R. Garlet, Vera Cavalli, A. Zamoner, J. D. da Rosa, et al. “Antioxidant Intervention Attenuates Oxidative Stress in Children and Teenagers with Down Syndrome.” Research in Developmental Disabilities, vol. 35, no. 5, 2014, pp. 1057–1065.
Pogribna, M., Stepan Melnyk, I. P. Pogribny, A. Chango, Ping Yi, et al. “Homocysteine Metabolism in Children with Down Syndrome: In Vitro Modulation.” American Journal of Human Genetics, vol. 69, no. 1, 2001, pp. 88–95.
Ptomey, Lauren T., J. Donnelly, Jeffery Burns, Jill K. Morris, Sigan L. Hartley, et al. “Brain Outcomes with Lifestyle Change in Adults with Down Syndrome: Rationale and Design for a 12‐Month Randomized Trial.” Alzheimer’s & Dementia, 2025.
Revilla, Noemí Rueda, and C. Martínez-Cué. “Antioxidants in Down Syndrome: From Preclinical Studies to Clinical Trials.” Antioxidants, vol. 9, no. 2, 2020, p. 160.
Scala, Iris, D. Valenti, Valentina Scotto D’Aniello, M. Marino, M. P. Riccio, et al. “Epigallocatechin-3-Gallate Plus Omega-3 Restores the Mitochondrial Complex I and F0F1-ATP Synthase Activities in PBMCs of Young Children with Down Syndrome: A Pilot Study of Safety and Efficacy.” Antioxidants, vol. 10, no. 1, 2021, p. 65.
Scoppola, Vittorio, A. Crudele, Antonella Mosca, N. Panera, Chiara di Camillo, et al. “Lifestyle Intervention Improves Metabolic Dysfunction-Associated Steatotic Liver Disease in Children with Down Syndrome.” Nutrients, vol. 17, no. 1, 2025, p. 140.
Stipoljev, F., A. Vičić, and R. Gjergja-Juraški. “Impact of Medical History, Diet and Lifestyle on Chromosomal Instability in Lymphocytes of Young Couples with Trisomy 21 Pregnancy.” Reproductive Toxicology, vol. 90, 2019, p. 153.
Tiano, Luca, and J. Busciglio. “Mitochondrial Dysfunction and Down’s Syndrome: Is There a Role for Coenzyme Q10?” BioFactors, vol. 37, no. 5, 2011, pp. 386–392.
Torres, A. “Aspectos Nutricionais Associados ao Envelhecimento de Indivíduos com Síndrome de Down: Uma Revisão Integrativa.” Revista Brasileira de Geriatria e Gerontologia, 2017.
Vacca, R. A., D. Valenti, S. Caccamese, M. Daglia, N. Braidy, et al. “Plant Polyphenols as Natural Drugs for the Management of Down Syndrome and Related Disorders.” Neuroscience and Biobehavioral Reviews, vol. 71, 2016, pp. 865–877.
Wernio, E., A. Kłosowska, A. Kuchta, Agnieszka Ćwiklińska, K. Sałaga-Zaleska, et al. “Analysis of Dietary Habits and Nutritional Status of Children with Down Syndrome in the Context of Lipid and Oxidative Stress Parameters.” Nutrients, vol. 14, no. 9, 2022, p. 1914.
Williams, G., J. Hamilton-Shield, K. M. Gillespie, and S. Leary. “Feeding and Autoimmunity in Down’s Syndrome Evaluation Study.” Reproductive Toxicology, vol. 90, 2016, p. 49.
Zaki, M., H. El-Bassyouni, A. M. Tosson, E. Youness, and J. Hussein. “Coenzyme Q10 and Pro-Inflammatory Markers in Children with Down Syndrome: Clinical and Biochemical Aspects.” Jornal de Pediatria, vol. 93, no. 1, 2017, pp. 59–64.